Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression
Crossref DOI link: https://doi.org/10.1007/s00262-015-1660-1
Published Online: 2015-02-07
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Noguchi, Masanori
Arai, Gaku
Matsumoto, Kazumasa
Naito, Seiji
Moriya, Fukuko
Suekane, Shigetaka
Komatsu, Nobukazu
Matsueda, Satoko
Sasada, Tetsuro
Yamada, Akira
Kakuma, Tatsuyuki
Itoh, Kyogo
Text and Data Mining valid from 2015-02-07